KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Times Interest Earned (2017 - 2025)

Aquestive Therapeutics (AQST) has 8 years of Times Interest Earned data on record, last reported at -$10.38 in Q4 2025.

  • For Q4 2025, Times Interest Earned fell 112.46% year-over-year to -$10.38; the TTM value through Dec 2025 reached -$6.39, down 130.94%, while the annual FY2025 figure was -$6.39, 130.94% down from the prior year.
  • Times Interest Earned reached -$10.38 in Q4 2025 per AQST's latest filing, down from -$4.13 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $0.02 in Q2 2024 and bottomed at -$10.38 in Q4 2025.
  • Average Times Interest Earned over 5 years is -$4.36, with a median of -$3.65 recorded in 2024.
  • Peak YoY movement for Times Interest Earned: soared 100.65% in 2024, then plummeted 20754.23% in 2025.
  • A 5-year view of Times Interest Earned shows it stood at -$6.69 in 2021, then increased by 2.96% to -$6.49 in 2022, then soared by 73.5% to -$1.72 in 2023, then tumbled by 183.98% to -$4.89 in 2024, then plummeted by 112.46% to -$10.38 in 2025.
  • Per Business Quant database, its latest 3 readings for Times Interest Earned were -$10.38 in Q4 2025, -$4.13 in Q3 2025, and -$4.09 in Q2 2025.